Demand-driven Management of Essential Tremor
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 18 - 80 |
| Updated: | 5/18/2018 |
| Start Date: | February 2015 |
| End Date: | February 2020 |
| Contact: | Andrew Ko, MD |
| Email: | alko00@u.washington.edu |
| Phone: | 206-543-3570 |
The Application of DBS Technologies for Demand-driven Management of Essential Tremor
This study evaluates the effectiveness of tremor control using various strategies for
implementing demand-driven thalamic deep brain stimulation (DBS) for essential tremor.
Therapeutic stimulation at the Vim nucleus of the thalamus will be initiated and modulated
using signals derived from external sensors (e.g. EMG, accelerometer) and cortical or
thalamic electrodes.
implementing demand-driven thalamic deep brain stimulation (DBS) for essential tremor.
Therapeutic stimulation at the Vim nucleus of the thalamus will be initiated and modulated
using signals derived from external sensors (e.g. EMG, accelerometer) and cortical or
thalamic electrodes.
Essential tremor is effectively treated with deep brain stimulation of the ventralis
intermedius nucleus of the thalamus, presumably because high-frequency stimulation disrupts
aberrant cerebellar-thalamic input. For the most part, patients with essential tremor have a
kinetic tremor that is present or worsened with movement. However, DBS therapy is currently
continuous, and thus, stimulation occurs when the patient will not benefit symptomatically
from treatment. This exposes the patient to unnecessary stimulation, which can lead to
unnecessary usage of battery, unnecessary exposure to stimulation side-effects, and can
possibly contribute to tolerance to DBS therapy.
One possible solution is selective stimulation when movement is required. This study will
determine signals predictive of motor activity using external sensors such as EMG, and
cortical biomarkers of real and imaginary movement that are well-characterized.
The primary aim is to demonstrate successful initiation and modulation of DBS therapy using
the Activa PC+S system and implanted cortical or thalamic electrodes. Putative improvements
in battery usage related to stimulation on-time and definition of coupling signals between
thalamus and cortex that characterize tremor state are secondary outcomes.
intermedius nucleus of the thalamus, presumably because high-frequency stimulation disrupts
aberrant cerebellar-thalamic input. For the most part, patients with essential tremor have a
kinetic tremor that is present or worsened with movement. However, DBS therapy is currently
continuous, and thus, stimulation occurs when the patient will not benefit symptomatically
from treatment. This exposes the patient to unnecessary stimulation, which can lead to
unnecessary usage of battery, unnecessary exposure to stimulation side-effects, and can
possibly contribute to tolerance to DBS therapy.
One possible solution is selective stimulation when movement is required. This study will
determine signals predictive of motor activity using external sensors such as EMG, and
cortical biomarkers of real and imaginary movement that are well-characterized.
The primary aim is to demonstrate successful initiation and modulation of DBS therapy using
the Activa PC+S system and implanted cortical or thalamic electrodes. Putative improvements
in battery usage related to stimulation on-time and definition of coupling signals between
thalamus and cortex that characterize tremor state are secondary outcomes.
Inclusion Criteria:
- Appropriate candidates for DBS with essential tremor
Exclusion Criteria:
- Not meeting inclusion criteria based on tremor amplitude, neuropsychological testing,
etc.
- Prior trauma to the brain on side of putative implantation of stimulator
We found this trial at
1
site
Seattle, Washington 98195
Principal Investigator: Andrew L Ko, MD
Phone: 206-543-3570
Click here to add this to my saved trials
